• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of a series of novel CCKB antagonists using a functional assay in the rat central nervous system.利用大鼠中枢神经系统功能试验对一系列新型胃泌素胆囊收缩素B拮抗剂进行评估。
Br J Pharmacol. 1994 Jun;112(2):666-70. doi: 10.1111/j.1476-5381.1994.tb13127.x.
2
Benzodiazepine/cholecystokinin interactions at functional CCK receptors in rat brain.大鼠脑中功能性胆囊收缩素受体处苯二氮䓬与胆囊收缩素的相互作用
Br J Pharmacol. 1994 Jun;112(2):429-34. doi: 10.1111/j.1476-5381.1994.tb13090.x.
3
Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.在小鼠和大鼠大脑皮层进行的放射性配体结合试验中,对选定的CCKB/胃泌素受体拮抗剂的行为分析。
Br J Pharmacol. 1999 Mar;126(6):1496-503. doi: 10.1038/sj.bjp.0702448.
4
Pharmacological analysis of the CCKB/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat.对介导未成熟大鼠离体胃中五肽胃泌素刺激胃酸分泌的CCKB/胃泌素受体的药理学分析。
Br J Pharmacol. 1996 Dec;119(7):1401-10. doi: 10.1111/j.1476-5381.1996.tb16052.x.
5
CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.CR 2945:一种具有抗焦虑样活性的新型CCKB受体拮抗剂。
Behav Pharmacol. 1998 May;9(3):183-94.
6
Effects of cholecystokinin and related peptides on neuronal activity in the ventromedial nucleus of the rat hypothalamus.胆囊收缩素及相关肽对大鼠下丘脑腹内侧核神经元活动的影响。
Br J Pharmacol. 1988 May;94(1):246-52. doi: 10.1111/j.1476-5381.1988.tb11521.x.
7
Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.苯二氮䓬脒衍生物L-740,093的生物学特性,一种在体外具有高亲和力且在体内具有高效能的胆囊收缩素-B/胃泌素受体拮抗剂。
Mol Pharmacol. 1994 Nov;46(5):943-8.
8
Analysis of variation in L-365,260 competition curves in radioligand binding assays.放射性配体结合试验中L-365,260竞争曲线的变异分析。
Br J Pharmacol. 1996 Aug;118(7):1717-26. doi: 10.1111/j.1476-5381.1996.tb15597.x.
9
Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays.在大鼠、豚鼠和小鼠离体胃组织试验中对L-365,260作用于CCKB/胃泌素受体的变化情况进行分析。
Br J Pharmacol. 1996 Aug;118(7):1779-89. doi: 10.1111/j.1476-5381.1996.tb15604.x.
10
Tolbutamide excites rat glucoreceptive ventromedial hypothalamic neurones by indirect inhibition of ATP-K+ channels.甲苯磺丁脲通过间接抑制ATP-K⁺通道来兴奋大鼠下丘脑腹内侧葡萄糖感受神经元。
Br J Pharmacol. 1990 Nov;101(3):531-40. doi: 10.1111/j.1476-5381.1990.tb14116.x.

引用本文的文献

1
Small synthetic ligands of the cholecystokinin-B/gastrin receptor can mimic the function of endogenous peptide hormones.胆囊收缩素B/胃泌素受体的小型合成配体可模拟内源性肽类激素的功能。
Yale J Biol Med. 1998 May-Aug;71(3-4):337-46.
2
Cholecystokinin receptors.胆囊收缩素受体
Cell Mol Neurobiol. 1995 Oct;15(5):545-59. doi: 10.1007/BF02071316.

本文引用的文献

1
Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists.胆囊收缩素二肽类似物拮抗剂:一些新型CCK-A和CCK-B选择性及“混合”CCK-A/CCK-B拮抗剂的设计、合成与抗焦虑特性
J Med Chem. 1993 Mar 5;36(5):552-65. doi: 10.1021/jm00057a005.
2
Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide.
Science. 1984 Apr 27;224(4647):395-6. doi: 10.1126/science.6546809.
3
Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia.神经肽缩胆囊素作为阿片类镇痛拮抗剂的证据。
Science. 1983 Jan 21;219(4582):310-2. doi: 10.1126/science.6294831.
4
Cholecystokinin decreases food intake in rats.胆囊收缩素可减少大鼠的食物摄入量。
J Comp Physiol Psychol. 1973 Sep;84(3):488-95. doi: 10.1037/h0034870.
5
Effects of cholecystokinin and related peptides on neuronal activity in the ventromedial nucleus of the rat hypothalamus.胆囊收缩素及相关肽对大鼠下丘脑腹内侧核神经元活动的影响。
Br J Pharmacol. 1988 May;94(1):246-52. doi: 10.1111/j.1476-5381.1988.tb11521.x.
6
Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.一种极具效力和选择性的非肽类胆囊收缩素拮抗剂的生化及药理学特性
Proc Natl Acad Sci U S A. 1986 Jul;83(13):4923-6. doi: 10.1073/pnas.83.13.4923.
7
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.肽激素胆囊收缩素强效、口服有效的非肽类拮抗剂的设计。
Proc Natl Acad Sci U S A. 1986 Jul;83(13):4918-22. doi: 10.1073/pnas.83.13.4918.
8
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.药物发现方法:强效、选择性、口服有效的胆囊收缩素拮抗剂的研发
J Med Chem. 1988 Dec;31(12):2235-46. doi: 10.1021/jm00120a002.
9
A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.一种新型强效选择性非肽类胃泌素拮抗剂及脑胆囊收缩素受体(CCK - B)配体:L - 365,260。
Eur J Pharmacol. 1989 Mar 21;162(2):273-80. doi: 10.1016/0014-2999(89)90290-2.
10
Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors.由系统性注射胆囊收缩素诱导的进食减少是由CCK-A受体介导的证据。
Eur J Pharmacol. 1989 Dec 7;173(2-3):233-4. doi: 10.1016/0014-2999(89)90528-1.

利用大鼠中枢神经系统功能试验对一系列新型胃泌素胆囊收缩素B拮抗剂进行评估。

Evaluation of a series of novel CCKB antagonists using a functional assay in the rat central nervous system.

作者信息

Boden P R, Pinnock R D, Pritchard M C, Woodruff G N

机构信息

Parke-Davis Neuroscience Research Centre, Addenbrookes Hospital Site, Cambridge.

出版信息

Br J Pharmacol. 1994 Jun;112(2):666-70. doi: 10.1111/j.1476-5381.1994.tb13127.x.

DOI:10.1111/j.1476-5381.1994.tb13127.x
PMID:8075886
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1910345/
Abstract
  1. Electrophysiological recordings from rat ventromedial hypothalamus (VMH) in vitro have been used to compare the effects of novel chemical entities on CCKB receptor activation in the rat central nervous system. 2. Twenty compounds from three different chemical series were evaluated for their ability to reduce pentagastrin-induced increases in action potential firing rate. 3. All twenty compounds studies were found to be CCKB antagonists, with equilibrium constants spanning a concentration-range of several orders of magnitude. The rank order for their ability to block pentagastrin responses correlated well with values obtained for their relative affinities for the mouse cortex CCKB binding site. 4. It is concluded that the VMH preparation provides a good functional correlate to binding assays in the rodent central nervous system for a structurally diverse series of CCKB antagonists.
摘要
  1. 体外大鼠腹内侧下丘脑(VMH)的电生理记录已被用于比较新型化学实体对大鼠中枢神经系统中CCKB受体激活的影响。2. 评估了来自三个不同化学系列的二十种化合物降低五肽胃泌素诱导的动作电位发放率增加的能力。3. 所研究的所有二十种化合物均被发现是CCKB拮抗剂,其平衡常数跨越几个数量级的浓度范围。它们阻断五肽胃泌素反应的能力的排名顺序与它们对小鼠皮质CCKB结合位点的相对亲和力所获得的值相关性良好。4. 得出的结论是,VMH制剂为啮齿动物中枢神经系统中一系列结构多样的CCKB拮抗剂的结合测定提供了良好的功能相关性。